12:00 AM
 | 
May 03, 2004
 |  BioCentury  |  Finance

Almost running the table

Almost running the table

Company 1Q04EPS est 1Q04EPS actual Outcome Growth from 1Q03 4/30cls Wk chg %chg Mcap chg 4/30Mcap
Actelion NA CHF1.27 NA 568% CHF142.25 CHF5.75 4% $92.3 $2,400.0
Sales of pulmonary arterial hypertension (PAH) drug Tracleer increased 60% to CHF97.1M from CHF60.7M in the same period last year.
Applied Biosystems $0.21 $0.21 Met 11% $18.57 ($0.83) -4% ($159.6) $3,830.0
EPS excludes a $0.02 charge for severance and related costs, a gain of $0.02 from legal settlements, and a $0.01 gain from the sale of investments. For FY04, ABI reiterated its guidance...

Read the full 654 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >